Implementation Strategies Used to Increase Human Papillomavirus Vaccination Uptake by Adolescent Girls in Sub-Saharan Africa: A Scoping Review

Barriers to successful implementation of the human papillomavirus vaccination exist. However, there is limited evidence on implementation strategies in sub-Saharan Africa (SSA). Therefore, this scoping review aimed to identify implementation strategies used in SSA to increase HPV vaccination uptake for adolescent girls. This scoping review was guided by Joanna Briggs Institute guidelines for scoping reviews and an a priori protocol and reported based on the Preferred Reporting Items for Systematic Reviews and Metanalysis for Scoping Reviews (PRISMA-ScR). We searched PubMed, EMBASE, CINAHL, Scopus, Google Scholar, and gray literature. Two independent reviewers screened article titles and abstracts for possible inclusion, reviewed the full text, and extracted data from eligible articles using a structured data charting table. We identified strategies as specified in the Expert Recommendation for Implementing Change (ERIC) and reported their importance and feasibility. We retrieved 246 articles, included 28 of these, and identified 63 of the 73 ERIC implementation strategies with 667 individual uses, most of which were highly important and feasible. The most frequently used discrete strategies included the following: Build a coalition and change service sites 86% (24/28), distribute educational materials and conduct educational meetings 82% (23/28), develop educational materials, use mass media, involve patients/relatives and families, promote network weaving and stage implementation scale up 79% (22/28), as well as access new funding, promote adaptability, and tailor strategies 75% (21/28). This scoping review shows that implementation strategies of high feasibility and importance were frequently used, suggesting that some strategies may be cross-cutting, but should be contextualized when planned for use in any region.

[1]  A. Rao,et al.  The impact of health education interventions on HPV vaccination uptake, awareness, and acceptance among people under 30 years old in India: a literature review with systematic search , 2023, Frontiers in Reproductive Health.

[2]  M. Lubeya,et al.  Correlates of Parental Consent to Human Papillomavirus Vaccine Uptake by Their Adolescent Daughters in ZAMBIA: Application of the Health Belief Model , 2023, Vaccines.

[3]  L. Abdullahi,et al.  Communication strategies to improve human papillomavirus (HPV) immunisation uptake among adolescents in sub-Saharan Africa: a systematic review and meta-analysis , 2023, BMJ Open.

[4]  M. Lubeya,et al.  Knowledge, attitude and practice towards cervical cancer screening among women living with human immunodeficiency virus: Implication for prevention strategy uptake , 2022, Nursing open.

[5]  One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer , 2022, Saudi medical journal.

[6]  M. Lubeya,et al.  Implementation strategies to increase human papillomavirus vaccination uptake for adolescent girls in sub-Saharan Africa: A scoping review protocol , 2022, medRxiv.

[7]  M. Lubeya,et al.  Knowledge, Attitudes and Practices Towards Human Papillomavirus Vaccination Among Medical Doctors at a Tertiary Hospital: A Cross Sectional Study , 2022, Cancer control : journal of the Moffitt Cancer Center.

[8]  D. Ross,et al.  Promoting adolescent health through integrated human papillomavirus vaccination programs: The experience of Togo. , 2021, Vaccine.

[9]  P. Sasieni,et al.  The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study , 2021, The Lancet.

[10]  R. Doshi,et al.  National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learned. , 2021, Vaccine.

[11]  Amy Jones,et al.  Using branded behaviour change communication to create demand for the HPV vaccine among girls in Malawi: An evaluation of Girl Effect's Zathu mini magazine. , 2021, Vaccine.

[12]  D. Watson-Jones,et al.  Adolescent Health Series: HPV infection and vaccination in sub‐Saharan Africa: 10 years of research in Tanzanian female adolescents ‐ narrative review , 2021, Tropical medicine & international health : TM & IH.

[13]  P. Manangazira,et al.  HPV vaccination coverage in three districts in ZIMBABWE following national introduction of 0,12 month schedule among 10 to 14 year old girls. , 2021, Vaccine.

[14]  Kai Sun,et al.  The Impact of Video-Based Educational Interventions on Cervical Cancer, Pap Smear and HPV Vaccines , 2021, Frontiers in Public Health.

[15]  N. Basta,et al.  Why don’t adolescent girls in a rural Uganda district initiate or complete routine 2-dose HPV vaccine series: Perspectives of adolescent girls, their caregivers, healthcare workers, community health workers and teachers , 2021, PloS one.

[16]  A. Wiyeh,et al.  A Systematic Review of Interventions to Improve HPV Vaccination Coverage , 2021, Vaccines.

[17]  M. Lubeya,et al.  Cervical cancer and HIV in Zambian women. , 2021, Lancet Global Health.

[18]  C. Kalinda,et al.  Cervical cancer diagnosis and treatment delays in the developing world: Evidence from a hospital-based study in Zambia , 2021, Gynecologic oncology reports.

[19]  Anyie J. Li,et al.  National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation , 2021, Vaccine.

[20]  T. Nopsopon,et al.  Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis , 2021, EClinicalMedicine.

[21]  V. Tsu,et al.  National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects , 2021, Preventive medicine.

[22]  T. Habtewold,et al.  Cervical cancer screening uptake in Sub-Saharan Africa: a systematic review and meta-analysis , 2021, medRxiv.

[23]  R. Bednarczyk,et al.  Public Education Interventions and Uptake of Human Papillomavirus Vaccine: A Systematic Review , 2020, Journal of public health management and practice : JPHMP.

[24]  M. Lubeya,et al.  Mapping the cervical cancer screening cascade among women living with HIV in Johannesburg, South Africaa , 2020, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[25]  Micah D J Peters,et al.  Updated methodological guidance for the conduct of scoping reviews , 2020, JBI evidence synthesis.

[26]  Jill Olivier,et al.  Health systems constraints and facilitators of human papillomavirus immunization programmes in sub-Saharan Africa: a systematic review , 2020, Health policy and planning.

[27]  S. Boccia,et al.  Increasing HPV Vaccination Uptake among Adolescents: A Systematic Review , 2019, International journal of environmental research and public health.

[28]  S. Kaul,et al.  School-based human papillomavirus vaccination program for increasing vaccine uptake in an underserved area in Texas , 2019, Papillomavirus research.

[29]  Zachary Munn,et al.  The development of software to support multiple systematic review types: the Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI) , 2019, International journal of evidence-based healthcare.

[30]  M. Sekine,et al.  HPV vaccination in Japan: what is happening in Japan? , 2019, Expert review of vaccines.

[31]  B. Chilundo,et al.  Human papillomavirus vaccine delivery in Mozambique: identification of implementation performance drivers using the Consolidated Framework for Implementation Research (CFIR) , 2018, Implementation Science.

[32]  T. Aris,et al.  Achieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programme , 2018, BMC Public Health.

[33]  Zachary Munn,et al.  Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach , 2018, BMC Medical Research Methodology.

[34]  J. Namakula,et al.  Level and factors associated with uptake of human papillomavirus infection vaccine among female adolescents in Lira District, Uganda , 2018, The Pan African medical journal.

[35]  J. McGowan,et al.  PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation , 2018, Annals of Internal Medicine.

[36]  N. Muñoz,et al.  HPV vaccine confidence and cases of mass psychogenic illness following immunization in Carmen de Bolivar, Colombia , 2018, Human vaccines & immunotherapeutics.

[37]  R. Chilengi,et al.  Factors influencing vaccine acceptance and hesitancy in three informal settlements in Lusaka, Zambia , 2018, Vaccine.

[38]  S. Delany-Moretlwe,et al.  Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign , 2018, Global Health: Science and Practice.

[39]  B. Corcoran,et al.  Rapid response to HPV vaccination crisis in Ireland , 2018, The Lancet.

[40]  N. Basta,et al.  HPV vaccination strategies targeting hard-to-reach populations: Out-of-school girls in LMICs. , 2018, Vaccine.

[41]  Y. Qiao,et al.  Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis , 2017, The lancet. HIV.

[42]  A. Loke,et al.  The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic Review , 2017, Journal of primary care & community health.

[43]  K. Msyamboza,et al.  Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges , 2017, BMC Public Health.

[44]  D. Watson-Jones,et al.  Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries , 2017, PloS one.

[45]  C. Chigbu,et al.  The impact of community health educators on uptake of cervical and breast cancer prevention services in Nigeria , 2017, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[46]  Nicolas Wentzensen,et al.  Carcinogenic human papillomavirus infection , 2016, Nature Reviews Disease Primers.

[47]  E. Audureau,et al.  Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014 , 2016, BMC Health Services Research.

[48]  D. Watson-Jones,et al.  Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries , 2016, BMC Public Health.

[49]  G. Colditz,et al.  Interventions to Improve HPV Vaccine Uptake: A Systematic Review , 2016, Pediatrics.

[50]  D. Watson-Jones,et al.  The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries , 2016, Human vaccines & immunotherapeutics.

[51]  S. Stokley,et al.  Interventions to increase HPV vaccination coverage: A systematic review , 2016, Human vaccines & immunotherapeutics.

[52]  K. Anastos,et al.  An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan Africa , 2016, Journal of lower genital tract disease.

[53]  S. el-Halabi,et al.  Human Papillomavirus Vaccination Coverage Among School Girls in a Demonstration Project - Botswana, 2013. , 2015, MMWR. Morbidity and mortality weekly report.

[54]  J. Kirchner,et al.  Use of concept mapping to characterize relationships among implementation strategies and assess their feasibility and importance: results from the Expert Recommendations for Implementing Change (ERIC) study , 2015, Implementation Science.

[55]  L. Niccolai,et al.  Practice- and Community-Based Interventions to Increase Human Papillomavirus Vaccine Coverage: A Systematic Review. , 2015, JAMA pediatrics.

[56]  E. Mugisha,et al.  Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda. , 2015, African health sciences.

[57]  J. Kirchner,et al.  A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project , 2015, Implementation Science.

[58]  M. Botha,et al.  The Vaccine and Cervical Cancer Screen project 2 (VACCS 2): Linking cervical cancer screening to a two-dose HPV vaccination schedule in the South-West District of Tshwane, Gauteng, South Africa. , 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[59]  R. Sankaranarayanan,et al.  Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa. , 2013, Vaccine.

[60]  C. Lacey,et al.  The burden of human papillomavirus infections and related diseases in sub-saharan Africa. , 2013, Vaccine.

[61]  D. Watson-Jones,et al.  Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects☆ , 2013, Vaccine.

[62]  L. Menezes,et al.  Influences on parental acceptance of HPV vaccination in demonstration projects in Uganda and Vietnam. , 2013, Vaccine.

[63]  A. Rameshbabu,et al.  Barriers and Facilitators to HPV Vaccination: Perspectives from Malawian Women , 2013, Women & health.

[64]  L. Denny,et al.  High uptake of Gardasil vaccine among 9 - 12-year-old schoolgirls participating in an HPV vaccination demonstration project in KwaZulu-Natal, South Africa. , 2013, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[65]  M. Plummer,et al.  Global burden of human papillomavirus and related diseases. , 2012, Vaccine.

[66]  R. Hayes,et al.  Reasons for Receiving or Not Receiving HPV Vaccination in Primary Schoolgirls in Tanzania: A Case Control Study , 2012, PloS one.

[67]  C. Karema,et al.  Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. , 2012, Bulletin of the World Health Organization.

[68]  R. Hayes,et al.  Human Papillomavirus Vaccination in Tanzanian Schoolgirls: Cluster-Randomized Trial Comparing 2 Vaccine-Delivery Strategies , 2012, The Journal of infectious diseases.

[69]  J. Ladner,et al.  Assessment of eight HPV vaccination programs implemented in lowest income countries , 2012, BMC Public Health.

[70]  Enola K. Proctor,et al.  A Compilation of Strategies for Implementing Clinical Innovations in Health and Mental Health , 2012, Medical care research and review : MCRR.

[71]  R. Wamai,et al.  Assessing the Effectiveness of a Community-Based Sensitization Strategy in Creating Awareness About HPV, Cervical Cancer and HPV Vaccine Among Parents in North West Cameroon , 2012, Journal of Community Health.

[72]  Yuxiao Tang,et al.  Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. , 2011, Bulletin of the World Health Organization.

[73]  E. Clayton,et al.  COMMITTEE TO REVIEW ADVERSE EFFECTS OF VACCINES , 2011 .

[74]  N. Brewer,et al.  Longitudinal Predictors of Human Papillomavirus Vaccine Initiation Among Adolescent Girls in a High-Risk Geographic Area , 2011, Sexually transmitted diseases.

[75]  L. Bruni,et al.  Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. , 2010, The Journal of infectious diseases.

[76]  N. Muñoz,et al.  Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. , 2007, The Lancet. Infectious diseases.

[77]  J. de Pina-Cabral World , 2004, Science.

[78]  F. Godlee The World Health Organisation in Africa , 1994, British medical journal.

[79]  S. Stokley,et al.  Barriers to Human Papillomavirus Vaccination Among US Adolescents: A Systematic Review of the Literature , 2015 .

[80]  S. P. Akpabio World Health Organisation , 1983, British Dental Journal.